Literature DB >> 17258817

Alexithymia, somatization and negative affect in a community sample.

Phoebe E Bailey1, Julie D Henry.   

Abstract

Whilst alexithymia has been consistently linked to somatization, two prominent theoretical models lead to opposite predictions as to which of two proposed typologies of alexithymia will be particularly associated with somatic symptom reporting. In the present study, participants were recruited from a cross-section of the general adult population (n=301), and asked to complete a battery of self-report questionnaires which assessed alexithymia, somatization and negative affect. Collapsed across the whole sample, specific facets of alexithymia (enhanced fantasy life and difficulty identifying emotions) were significantly associated with somatization, and these pathways were perfectly mediated by negative affectivity. Further, type II alexithymia (impairment in the cognitive but not the affective dimension of alexithymia) was more predictive of somatization relative to type I alexithymia (impairment in both the cognitive and affective dimensions of alexithymia) and non-alexithymia (unimpaired in the cognitive and affective dimensions of alexithymia). The theoretical and clinical implications of these results are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17258817     DOI: 10.1016/j.psychres.2006.05.024

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  29 in total

1.  Alexithymia, depression, and cognition in patients with Parkinson's disease.

Authors:  Gulay Kenangil; Mehmet Demir; Esma Tur; Fusun Domac
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

2.  Alexithymia influences brain activation during emotion perception but not regulation.

Authors:  Jorien van der Velde; Paula M Gromann; Marte Swart; Durk Wiersma; Lieuwe de Haan; Richard Bruggeman; Lydia Krabbendam; André Aleman
Journal:  Soc Cogn Affect Neurosci       Date:  2014-04-23       Impact factor: 3.436

3.  Depression partially mediates the relationship between alexithymia and somatization in a sample of healthy children.

Authors:  Laura B Allen; Jennie C I Tsao; Loran P Hayes; Lonnie K Zeltzer
Journal:  J Health Psychol       Date:  2011-04-04

4.  Neuroanatomical profiles of alexithymia dimensions and subtypes.

Authors:  Katharina Sophia Goerlich-Dobre; Mikhail Votinov; Ute Habel; Juergen Pripfl; Claus Lamm
Journal:  Hum Brain Mapp       Date:  2015-06-19       Impact factor: 5.038

5.  Altered brain activity during emotional empathy in somatoform disorder.

Authors:  Moritz de Greck; Lisa Scheidt; Annette F Bölter; Jörg Frommer; Cornelia Ulrich; Eva Stockum; Björn Enzi; Claus Tempelmann; Thilo Hoffmann; Shihui Han; Georg Northoff
Journal:  Hum Brain Mapp       Date:  2011-10-13       Impact factor: 5.038

6.  Enhanced Connectivity of Thalamo-Cortical Networks in First-Episode, Treatment-Naive Somatization Disorder.

Authors:  Jin Zhao; Qinji Su; Feng Liu; Zhikun Zhang; Ru Yang; Wenbin Guo; Jingping Zhao
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

7.  Mental Symptoms in Different Health Professionals During the SARS Attack: A Follow-up Study.

Authors:  For-Wey Lung; Yi-Ching Lu; Yong-Yuan Chang; Bih-Ching Shu
Journal:  Psychiatr Q       Date:  2009-02-27

8.  Posttraumatic stress symptoms and well-being following relationship dissolution: past trauma, alexithymia, suppression.

Authors:  Man Cheung Chung; Laura J Hunt
Journal:  Psychiatr Q       Date:  2014-06

9.  Validity issues in the assessment of alexithymia related to the developmental stages of emotional cognition and language.

Authors:  Hiroki Nishimura; Gen Komaki; Tetsuya Igarashi; Yoshiya Moriguchi; Sohei Kajiwara; Toru Akasaka
Journal:  Biopsychosoc Med       Date:  2009-11-03

10.  Assessing Psychodynamic Conflicts and Level of Personality Functioning in Women Diagnosed With Vaginismus and Dyspareunia.

Authors:  Thula U Koops; Christian Wiessner; Johannes C Ehrenthal; Peer Briken
Journal:  Front Psychol       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.